Literature DB >> 21961824

The state of hormonal contraception today: established and emerging noncontraceptive health benefits.

Karla Maguire1, Carolyn Westhoff.   

Abstract

In the 50 years since the advent of combined oral contraceptives the amount of estrogen in oral contraceptives dropped from over 100 mcg to less than 30 mcg. Many noncontraceptive health benefits have emerged that decrease mortality and improve quality of life. Some of the immediate benefits include improvement of menorrhagia and dysmenorrhea, reduction in premenstrual dysphoric disorder symptoms, and decreased acne. As an effective birth control method oral contraceptives also decrease pregnancy-related deaths by preventing pregnancy. After the reproductive years, previous use of oral contraceptives continues to be beneficial, reducing the risk of death from ovarian and endometrial cancer. All these benefits have held up over time whereas cardiovascular risks have lessened because of the decrease in oral contraceptive pill dosage. Decreased ovarian cyst formation is an example of benefit with higher-dose oral contraceptive formulations that no longer holds true with low-dose pills.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21961824     DOI: 10.1016/j.ajog.2011.06.056

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  25 in total

Review 1.  Management of the Perimenopause.

Authors:  Lara Delamater; Nanette Santoro
Journal:  Clin Obstet Gynecol       Date:  2018-09       Impact factor: 2.190

2.  Half a century of the oral contraceptive pill: historical review and view to the future.

Authors:  Pamela Verma Liao; Janet Dollin
Journal:  Can Fam Physician       Date:  2012-12       Impact factor: 3.275

Review 3.  Neurovascular control of blood pressure is influenced by aging, sex, and sex hormones.

Authors:  Sarah E Baker; Jacqueline K Limberg; Sushant M Ranadive; Michael J Joyner
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-16       Impact factor: 3.619

4.  Hormonal contraception and pelvic girdle pain during pregnancy: a population study of 91,721 pregnancies in the Norwegian Mother and Child Cohort.

Authors:  E K Bjelland; P Kristiansson; H Nordeng; S Vangen; M Eberhard-Gran
Journal:  Hum Reprod       Date:  2013-07-25       Impact factor: 6.918

Review 5.  Contraception technology: past, present and future.

Authors:  Regine Sitruk-Ware; Anita Nath; Daniel R Mishell
Journal:  Contraception       Date:  2012-09-17       Impact factor: 3.375

6.  Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect.

Authors:  Murray Joseph Casey; Todd A Salzman
Journal:  Linacre Q       Date:  2018-07-20

7.  Oral ethinylestradiol-levonorgestrel attenuates cardiac glycogen and triglyceride accumulation in high fructose female rats by suppressing pyruvate dehydrogenase kinase-4.

Authors:  Kehinde Samuel Olaniyi; Lawrence Aderemi Olatunji
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-01       Impact factor: 3.000

8.  Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States.

Authors:  Katherine M Keyes; Keely Cheslack-Postava; Carolyn Westhoff; Christine M Heim; Michelle Haloossim; Kate Walsh; Karestan Koenen
Journal:  Am J Epidemiol       Date:  2013-09-15       Impact factor: 4.897

9.  Aging Alters the Relative Contributions of the Sympathetic and Parasympathetic Nervous System to Blood Pressure Control in Women.

Authors:  Sarah E Baker; Jacqueline K Limberg; Gabrielle A Dillon; Timothy B Curry; Michael J Joyner; Wayne T Nicholson
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

10.  Hormonal and reproductive risk factors for sporadic microsatellite stable and unstable endometrial tumors.

Authors:  Ernest K Amankwah; Christine M Friedenreich; Anthony M Magliocco; Rollin Brant; Thomas Speidel; Wahida Rahman; Linda S Cook
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-15       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.